EXTX — Exact Therapeutics AS Balance Sheet
0.000.00%
Last trade - 00:00
- NOK176.44m
- NOK131.21m
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 45 | 159 | 104 | 69.4 | 46.4 |
Net Total Receivables | 5.09 | 5.99 | 7.61 | 8.14 | 9.47 |
Total Other Current Assets | |||||
Total Current Assets | 50.6 | 166 | 111 | 77.5 | 55.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.46 | 4.52 | 6.33 | 4.97 | 5.42 |
Other Long Term Assets | |||||
Total Assets | 52.1 | 170 | 118 | 82.5 | 61.3 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9.83 | 10.6 | 10.5 | 16.1 | 15.5 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 9.87 | 10.6 | 11.9 | 17.4 | 16.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 42.2 | 160 | 106 | 65.1 | 45.1 |
Total Liabilities & Shareholders' Equity | 52.1 | 170 | 118 | 82.5 | 61.3 |
Total Common Shares Outstanding |